On Dec. 14, 2015, the FDA expanded Merck’s Gardasil 9 licensure to include males age 16ﾖ26 years. The inclusion of 16ﾖ26 year old males made the age indication for 9vHPV consistent with that of quadrivalent HPV vaccine (4vHPV), which is the other HPV vaccine licensed for use in males.